Caladrius Biosciences Inc.

(CLBS) Trade

By |

Profile

Caladrius Biosciences Inc is a company developing cellular therapeutics to treat certain diseases. The company has internal specialized cell therapy clinical development expertise to select and develop early-stage cell therapy candidates with the intention of partnering these candidates post proof-of-concept in humans. The product portfolio pf the group includes, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes in a enrolling Phase 2 trial.

Contact Information

Website: www.caladrius.com
Email: jmenditto@caladrius.com
Main Phone: +1 908 842-0100
Address: 106 Allen Road
Address 2: 2nd Floor
State: NJ
City / Town: Basking Ridge
Country: USA
Postal Code: 07920

Issuer Information

Exchange: NSC
CEO: David J. Mazzo
Employees: 22
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 4.78 $ 0.0406 (0.86%)
Last Price 4.78 Change $ 0.0406 Change % 0.86 Tick N/A
Bid 4.70 Bid Size 200.00 Ask 4.88 Ask Size 200.00
Open 4.75 High 4.98 Low 4.70 Prev Close 4.74
Last Trade Volume 7,360 52 Wk Hi 11.65 52 Wk Low 3.25
Market Cap 47.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 9,841,983.00 EPS (TTM) -1.68 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 7
Number of Buys 0 4
Number of Sells 0 3
Net Activity 0 101014
Last 10 Buys Shares
David J. Mazzo 1,000
Robert S. Vaters 1,000
Robert S. Vaters 1,000
Steven S. Myers 1,000
Steven S. Myers 1,000
Steven S. Myers 1,000
Steven S. Myers 1,000
Steven M. Klosk 1,000
Steven S. Myers 1,000
Steven S. Myers 1,000
Last 10 Sell Shares
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
Eric H.C. Wei 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 12 12 12 12
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 9.5 9.5 9.5 9.5
Standard Deviation 3.54 3.54 3.54 3.54
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1